RecruitingNCT04028531

Understanding Chronic Lymphocytic Leukemia


Sponsor

Dana-Farber Cancer Institute

Enrollment

2,750 participants

Start Date

Sep 29, 1999

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study that collects information and samples from patients with chronic lymphocytic leukemia (CLL) — a slow-growing blood cancer — and related conditions, to help researchers better understand how these diseases develop and respond to treatment over time. **You may be eligible if...** - You have been diagnosed with chronic lymphocytic leukemia (CLL), monoclonal B-cell lymphocytosis (a precursor condition), or another low-grade lymphoproliferative disorder (a slow-growing blood cell condition) - You are seen for treatment at Dana-Farber Cancer Institute or elsewhere **You may NOT be eligible if...** - There are no formal exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Dana Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04028531


Related Trials